2016
DOI: 10.1038/srep29048
|View full text |Cite
|
Sign up to set email alerts
|

Utilizing the micron sized non-thermal atmospheric pressure plasma inside the animal body for the tumor treatment application

Abstract: This study aimed to evaluate the effects of micron sized non-thermal atmospheric pressure plasma inside the animal body on breast cancer tumor. The μ-plasma jet consists of micron sized hollow tube in which pure helium gas is ionized by high voltage (4 kV) and high frequency (6 kHz). The efficiency of the plasma treatment in killing cancer cells was first investigated by cell viability measurements of treated 4T1 cells using flow cytometry and cell cycle analysis. For exploration of the in vivo effects of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
44
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(50 citation statements)
references
References 51 publications
(55 reference statements)
5
44
0
1
Order By: Relevance
“…[ 15,121 ] The therapeutic effects of CAP are not limited to cultured cancer cells in vitro, such as breast, melanoma, and colorectal cancer cells, [ 12 ] but also have been demonstrated in animal models. [ 176,177 ]…”
Section: Applications In Dermatologymentioning
confidence: 99%
“…[ 15,121 ] The therapeutic effects of CAP are not limited to cultured cancer cells in vitro, such as breast, melanoma, and colorectal cancer cells, [ 12 ] but also have been demonstrated in animal models. [ 176,177 ]…”
Section: Applications In Dermatologymentioning
confidence: 99%
“…Great efforts are currently made extending the range of plasma applications with different devices. This includes blood coagulation [Amritkar et al, 2013;Aleinik et al, 2017;Miyamoto et al, 2017], ophthalmology [Rosani et al, 2015;Ye et al, 2015;Recek et al, 2016], oncology [Ye et al, 2015;Mirpour et al, 2016;Binenbaum et al, 2017], and various diseases in dermatology [Daeschlein et al, 2010[Daeschlein et al, , 2011Klebes et al, 2014]. Addressing not only the efficacy but also safety of different plasma sources or their optimum operational settings, genotoxic testing is indispensable.…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, plasma administration for 3 min achieved tumour growth reduction comparable with chemotherapy. There was also significant change in the ratio of pro-and anti-apoptotic gene activity at the molecular level [127].…”
Section: Use Of Cap For Tumour Treatmentmentioning
confidence: 96%